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Aims. The realization of an experimental set-up for the quantitative and objective description of drawing using optoelectronic
systems, which could be used when a quantiﬁcation of the realization of speciﬁc drawing tests is required. Methods. Healthy
subjects, subjects with Parkinson’s Disease and subjects with Parkinson’s Disease and Dementia were evaluated by the Mini Mental
Scale Evaluation and by a new approach to the Clock Drawing Test, based on an optoelectronic acquisition. The new protocol
hereby described aims to deﬁne a parameter related to the movement kinematics in the Clock Drawing test execution. Results.T h e
experimental set-up revealed to be valid introducing new objective measurements beside the subjective Clock Drawing Test. This
paper suggests the applicability of this protocol to other ﬁelds of motor and cognitive valuation, as well as the introduction of new
parameters related to the graphic movement.
1.Introduction
Writing and drawing are the ﬁnal output of a complex neu-
rological, psychological, and motor action and can therefore
beusedtoinvestigateboththemovementcapabilitiesandthe
cognitive functions of the subjects.
Simple drawing tests are commonly used for the clinical
evaluation of cognitive capabilities, especially in the elderly,
inordertoassessthepresenceofdementiaandtoestimateits
extent.
Through the analysis of both the graphic gesture and
the drawing contents, it is therefore possible to obtain a
report of the subject’s psicophisical health. In the cognitive
deﬁcits, the presence of diﬀerent typologies of dementia
(Alzheimer’s disease AD, Mild Cognitive Impairment MCI,
and Parkinson’s disease dementia PDD) can be found.
The Clock Drawing Test (CDT) is a qualitative neu-
rological drawing test commonly used as a screening
instrument for cognitive capabilities in the senile popu-
lation and to evaluate the functional capabilities in the
elderly.
The test is easily administrable, requires little time, and
showsagoodsensitivityinmeasuringthecognitivefunctions
in the elderly.
The CDT can be administered in two modalities:
verbal command (command condition) and copying (copy
condition). In the ﬁrst one (command condition), the subject
is asked to draw a clock with the clock hands indicating a
particulartime(tenminutespasteleven)[1,2].Awell-drawn
clock is supposed to have the circle, numbers from 1 to 12 in
thecorrectorderandpositioninsidethecircle,andthehands
on the correct time.
It is also possible to give the subject a predrawn circle, in
o r d e rt oa v o i dt h a tab a d l yd r a w nc i r c l e ,o rat o os m a l lo n e ,
inﬂuences the rest of the drawing [2–4].2 Neurology Research International
The CDT command condition investigates the subject’s
language function (verbal comprehension) memory func-
tions (recall of a visual engram, short-term storage, recall of
time setting instructions), and executive function.
The test is highly sensitive for temporal lobe dysfunction
(due to its heavy involvement in both memory and language
processes), and frontal lobe dysfunction (due to its media-
tion of executive planning) [2].
In the second modality (copy condition), the subject is
given a printed clock, with the hands reading a certain
time, and he is asked to replicate the drawing sideways, as
accurately as possible.
This modality requires less use of language and memory
functions but requires greater reliance on visual-spatial
and perceptual processes. The copy condition is good for
assessing parietal lobe lesions [2]; this region is responsible
for stimuli recognition and for the recall of forms and
structures. It processes the visual-spatial relationships and
integrates proprioception with the other senses.
Asthetwomodalitiesinvestigatediﬀerentspheresofcog-
nitive impairment, it is important to submit both the tests: a
subject with a lesion of the temporal lobe would in fact copy
correctlythepredrawnclockbutwouldresultimpairedinthe
command condition, for instance, by an incorrect spacing of
the numbers or an incorrect representation of the clock face.
Oncontraryasubjectwithaparietallesionwouldadequately
draw the clock in the command condition but would show
pathologic features in the copy condition.
In order to assure better sensitiveness multiscale scoring
has been developed, which analyze both qualitative and
quantitative characteristics of the drawing. These are the
methods of Mendez, Cahn, and Freund which were adapted
by the quantitative scoring evaluation system of Rouleau [1].
In particular, the Mendez system assigns a maximum of 20
points based on the presence of various characteristics of the
clock, mostly related to the correct quantity and positioning
of numbers and hands and to the absence of nonappropriate
signs. According to the author healthy subjects do not
miss more than two points, while subjects with Alzheimer’s
disease miss at least three.
The test is commonly administered with the “pen and
sheet” modality, with no use of computerized methods of
acquisition,andtheclinicianvisuallydoestheevaluationand
scoring.
It is clear that this method involves great limitations in
terms of measurement. First of all, a visual assessment is not
completely inter- and intrarater reliable, because it is aﬀected
by the evaluator’s experience and subjectivity. Secondly, it
does not allow to memorize the temporal sequence of the
graphic signs on the sheet. Every information about the
temporal evolution of the graphic signs, such as reaction
time and duration, is therefore lost, with a loss of important
quantitative information.
The most of the cognitive assessment is therefore still
based on visual scoring systems, such as the ones described
for the CDT (i.e., Mendez, Roleau scoring systems) or the
widely used Mini Mental State Evaluation (MMSE).
Inordertobetterquantifythegestureintherealizationof
CDT, we developed a preliminary method for the acquisition
and analysis of cognitive drawing tests which allows to
evaluate both the qualitative and quantitative features of the
drawing.
The aims of this study are the following:
(1) the development of an experimental setup for cog-
nitive drawing tests, based on kinematic evaluation,
which is suitable for pathological subjects,
(2) the deﬁnition and computation of signiﬁcant param-
eters related to the execution of the CDT,
(3) the application of the experimental setup to a group
of subjects with Parkinson’s Disease (PD) and to
a group of subjects with Parkinson’s disease and
dementia (PDD), in order to demonstrate the clinical
applicability of the set up in patients with motor and
cognitive impairment.
Clinical application is suitable for subjects with PD, as
cognitive impairment and dementia have been highlighted
as particularly common nonmotor complications in the case
of Parkinson’s Disease.
Impaired cognitive domains in PDD include attention,
memory, visual-spatial, constructional and executive func-
tions [5, 6]. There are some indications from prospective
studies that executive deﬁcits may be the more important
predictors of subsequent decline. However, the relationship
between initial deﬁcits and subsequent proﬁle of dementia
has not been clearly established [5].
Typically, drawing tests are used to assess constructional
ability and praxis, either copying tasks or drawing common
objects. As it was previously explained, construction and
drawing tasks involve signiﬁcant motor control and a
range of cognitive functions. The contribution of motor
dysfunction to such deﬁcits has rarely been examined in
PDD.
2.MaterialsandMethods
The subjects were recruited in the San Raﬀaele Parkinson’s
disease Centre of Cassino, FR, Italy and were diagnosed on
the UK Brain Bank criteria. Healthy subjects were recruited
between the patients’ relatives. The study was approved by
the Ethics Research Committee of the San Raﬀaele Pisana,
Roma, Italy. All subjects were volunteers and gave informed
consent to participation in the study. The subjects were
evaluated with a standard clinical battery of tests.
All the testing of PD patients was carried out during the
ON phase, at their best motor condition, approximately 90
minutes after the ﬁrst dose of levodopa, in the morning.
All patients underwent a quantitative assessment of their
neurological condition using the Uniﬁed Parkinson’s Disease
Rating Scale (UPDRS). The scale is composed of six parts:
mentation, behaviour, and mood (UPDRS I); activities of
daily living (UPDRS II); motor examination (UPDRS III);
complications of treatment (UPDRS IV); a global disability
staging score (UPDRS V); a global activities of daily living
score (UPDRS VI). The severity of the extrapyramidal
symptoms was rated using the motor section of UPDRSNeurology Research International 3
Table 1: Group of PD and PDD subjects.
Diagnosis Age (years) Gender Years of PD UPDRS in ON Hoehn & Yahr in ON FIM in ON BI in ON MMSE GDS
PDD 62.0 f 2.0 37.0 2.5 84.0 72.0 18.3 13
PDD 66.0 f 10.0 20.0 3.0 79.0 63.0 18.2 11
PDD 75.0 m 5.0 32.0 3.0 85.0 73 20.0 13
PDD 77.0 f 19.0 49.0 3.0 56.0 49.0 16.7 11
PDD 81.0 f 9.0 44.0 3.0 77.0 71.0 22.5 15
PDD 84.0 f 8.0 36.0 3.0 82.0 64.0 23.4 7
PD 43.0 f 4.0 21.0 2.0 98.0 76.0 30.0 13
PD 57.0 m 10.0 26.0 2.0 99.0 79.0 28.7 11
PD 61.0 f 4.0 36.0 3.0 88.0 56.0 28.5 13
PD 63.0 f 20.0 21.0 3.0 92.0 84 29.0 10
PD 65.0 f 4.0 34.0 2.5 99 90 26.2 8
PD 67.0 f 8.0 36.0 3.0 98.0 30.0 25.2 11
PD 69.0 f 6.0 47.0 3.0 87.0 69 26.0 15
PD 71.0 f 6.0 30.0 3.0 79.0 70.0 27.3 11
PD 76.0 m 6.0 22.0 3.0 81.0 72.0 27.0 12
(UPDRS III), the score for this part ranges from 0 to 108,
and a higher score denotes greater disability.
The functional status was assessed at the beginning and
at the end of hospitalization by the Functional Independence
Measure (FIM), which measures the overall functional
disability. The scale includes 18 items, of which 13 are
physicaldomainsbasedontheBarthelIndex(BI)and5items
are cognition items. Each item is scored from 1 to 7 based on
level of independence, where 1 represents total dependence.
Possible scores range from 18 to 126, with higher scores indi-
cating higher independence. The subjects underwent brain
computed tomography and a complete neuropsychiatric
evaluation. In order to summarize the cognitive conditions
of the subjects, the Mini Mental State Evaluation (MMSE)
and the Geriatric Depression Scale (GDS) were used for
rating dementia and depression, respectively. According to
the clinical MMSE scale a score inferior to 24/30 reveals the
presenceofdementia[4,7].GDSassignsascoreofincreasing
depression level from 0 to 30.
Ten healthy subjects were evaluated in order to compose
a control group (CG). Their mean age was 52.3 ± 11.7y e a r s
(agerangefrom52to73years)andconsistedof6femalesand
4 males. Then nine subjects with Parkinson’s Disease (PD,
mean age = 63.6+9 .5y e a r s )a n ds i xs u b j e c t sw i t hP Da n d
dementia(PDD,mean age = 74.2+8.6years)wereevaluated.
Data related to PD and PDD subjects are reported in
Table 1. For every subject, the scores of the Uniﬁed Parkin-
son’s Disease Rating Scale (UPDRS-III), the Functional
Independence Measure (FIM), the Barthel Index (BI), the
Mini Mental State Examination (MMSE), and the Geriatric
Depression Scale (GDS) were detailed.
The graphic gesture was acquired with an optoelectronic
system with six cameras (SMART, BTS, Italy), at a frequency
of 120Hz, and with an integrated video system (Vixta, BTS,
Italy) for videorecording.
The optoelectronic system is an equipment able to
measures the 3D coordinates (X, Y, Z)o fr e ﬂ e c t i v em a r k e r s .
Theacquisitionwasobtainedbyusingmarkersofdiameter =
10mm in the conﬁgurations described in what follows.
The ﬁrst conﬁguration, shown in Figure 1(a),w a su s e d
for a static acquisition, in which the subject did not take
part; the pen was laid on the table and the markers were
acquired for ﬁve seconds, in order to calculate the position
of the tip of the pen and allow the calculation of its position
duringthedynamicacquisition,inwhichthegraphictestwas
executed by the subject. In the dynamic acquisition markers
were positioned both on the sheet and on the pen (as shown
in Figure 1(b)).
The CDT test was composed of two trials. In the ﬁrst
one (command condition), the subject was verbally asked to
“draw a clock inside the predrawn circle and then draw the
clock hands to indicate ten minutes past eleven.”
In the second task (copy condition), the subject was asked
to copy, inside a printed circle, the clock shown on the paper.
Data reconstruction was carried out using the software
Smart Tracking (BTS, S.p.a), which computes the tracking
phase. After the tracking the acquisitions were computed
using Smart Analyzer software (BTS, Italy, Version 1.10),
which creates procedures ad hoc for the extraction of indexes
of interest, angles, and trajectories. With this software, an
algorithm was deﬁned for the automatic calculation of the
parameters of interest and for the realization of the related
report.
The Trial duration, TD,[s]o ft h et r i a lw a sc o m p u t e d
using Smart Analyzer, in order to assess the reasoning and
decision-taking time of PD and PDD subjects.
An example of the layout of the test, obtained with Smart
Analyzer software, is shown in Figure 2.
2.1. Statistical Analysis. Data were grouped by three cate-
gories: healthy control group subjects (CG), subjects with
Parkinson’s Disease (PD), and subjects with Parkinson’s
Disease Dementia (PDD). PD and PDD subjects were both4 Neurology Research International
Table 2: Trial duration (mean and standard deviations) for the three groups and for both drawing conditions.
Trial Duration (TD) [s]
CDT Command CDT Copy
Mean St Dev P-value Mean St Dev P-value
CG 44.6 14.1 44.1 11.7
PD 77.4 46.4
∗
 55.7 18.8
∗

PDD 195.9 57.1 124.2 37.3
∗: P-value <. 05 for PD versus PDD; : P-value <. 05 for CG versus PDD; •: P-value <. 05 for CG versus PD.
evaluated in the on-medication phase (on levodopa treat-
ment). For each group the mean and standard deviations
were calculated.
In order to give statistical validity to the chosen parame-
ters, some statistic tests were done with the use of Statistica
software (Version 7.0). For every test, the P-value was taken
into account, its signiﬁcance threshold being .05, so that
values minor than the threshold were considered statistically
signiﬁcant.
First a normality test (Lilliefors and Kolmogorov-Smir-
nov tests) was done to verify the kind of distribution of
the parameters. Comparison between independent samples
(i.e., PD versus PDD) was assessed with the Mann-Whitney
U-Test. Partial correlation analysis was used to determine
whether the correlation between the variables of interest still
held once controlling for a third “confounding” variable.
3. Results andDiscussion
Statistical analysis of the duration index revealed diﬀerences
b e t w e e nP Da n dP D Ds u b j e c t si nb o t hc o m m a n da n dc o p y
conditions. The means and standard deviations of trial
duration, for the two trials and the three groups, are detailed
in Table 2.
The CG subjects draw with comparable durations for the
two tasks. No statistically signiﬁcant diﬀerence was found,
for duration, between CG and PD subjects, while there
was diﬀerence between CG and PDD and between PD and
PDD.
Performances were slower for both PD and PDD groups
in the command condition. It can be noticed that, for both
command and copy conditions, PD draw faster than PDD.
TDisatemporalparameter,anditcanbethereforeinﬂu-
enced by the presence of motor deﬁcits such as bradykinesia,
which are characteristic of Parkinson’s Disease. In order to
evaluate the validity of the trial duration (TD index) in the
assessment of cognitive function, we calculated the partial
correlation between MMSE and duration for the whole
PD and PDD subjects, while controlling for the UPDRS
III scores. The degree of motor impairment, in fact, could
act as a confounding variable and therefore impact on the
correlation between the variables of interest (MMSE and
TD). The partial correlation between MMSE and TD was
strong (command condition r =− 0.75; copy condition r =
−0.81) when controlling for motor impairment, meaning
(a)
Y
X
Z
(b)
Figure 1: (a) Position of the markers for the static acquisition. (b)
Position of the markers for the dynamic acquisition.
that UPDRS III is not inﬂuencing the correlation. In Figures
3 and 4, the statistically signiﬁcant correlation between
the MMSE scoring and TD for both drawing conditions
is shown; the correlation is negative, meaning that lower
MMSE (therefore higher degrees of cognitive dysfunction)
led to higher reasoning time and thus to higher duration of
the trials.
The correlation was higher in the command condition
trial, meaning that a stronger relation occurred between
degree of dementia and duration of the trial in the command
condition. This result can be interpreted in the light of
the characteristics of PDD dysfunctions: the command
condition, in fact, studies the impairments related to the
frontal lobe, where executive function is processed. As this
function generally appears to be the most compromised
in PDD, we expected a higher diﬃculty in the command
conditiontask,andthushigherdurationsofthetrials(longer
decision taking and executive time).Neurology Research International 5
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Figure 2: An example report of the Clock Drawing Test obtained
with Smart Analyzer software, drawn by a CG subject.
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Figure 3: Relation between the MMSE scoring and duration in the
CDT command condition (r =− 0.75). Squares are PDD, circles are
PD.
4. Conclusions
In this study, an experimental setup was deﬁned for the
quantitative and objective assessment of cognitive drawing
tests. This setup was ﬁrstly applied to a group of healthy
subjects (CG), then to a group of subjects with Parkinson’s
Disease (PD), and to a group of subjects with Parkinson’s
Disease and dementia (PDD), to assess the validity of the
setup in the clinical usage.
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Figure 4: Relation between the MMSE scoring and duration in the
CDTcopycondition(r =− 0.81).SquaresarePDD,circlesarePD.
The graphic gesture was acquired with an optoelectronic
system with six cameras. Markers were put on the pen and
on the sheet.
The subjects were asked to execute the Clock Drawing
Test (CDT), a commonly used clinical test for the assessment
of cognitive dysfunction. The test was administered in two
diﬀerent modalities: the command and the copy conditions.
Each of these investigates speciﬁc cerebral areas and thus is
sensitive to diﬀerently located brain damages [2].
Rather than concentrating on the CDT scoring itself, our
aim was to develop a quantitative measurement. The CDT,
in fact, has always been visually rated by the clinician, while
only a few attempts were made to introduce objective and
quantitative parameters [3].
We analyzed duration of the trials (Trial Duration, TD)
for the two conditions of test. We found, indeed, that
duration of the trial can be a useful, objective parameter for
the assessment of cognitive performance.
The calculation of the partial correlation between MMSE
scores and duration of the trials, with control of the
UPDRS III variable, revealed that motor impairment did not
signiﬁcantlyimpactonthecorrelationbetweentrialduration
and MMSE; the strong negative correlation showed that a
higher degree of dementia led to longer durations of the
trials, presumably because the impaired subjects had more
reasoning diﬃculties. In particular, PDD subjects appeared
to be more compromised in terms of executive function,
which is investigated by the CDT command condition. Both
PDandPDDperformedfasterinthecopycondition,butstill
there was statistically signiﬁcant diﬀerence between the two
groups in both the trials. As the two conditions investigate
diﬀerent cognitive areas, we can suggest that the cognitive
diﬃculty was less severe in the copy condition.
Alltrialsrevealedtobewelltoleratedbythesubjects,who
were able to complete the requested tasks without excessive
fatigue.
The optoelectronic system revealed to be advantageous
both for a quantitative measurement of the parameters
and for being a practical, noninvasive technique; it allowed
the subjects to freely draw, recreating the “pen and sheet”
condition and thus allowing natural movements.6 Neurology Research International
The test was completely not invasive and did not limit
in any way the subject’s motion. The application of the
markers on the pen and the sheet did not require a speciﬁc
competence, as it would have been, for instance, in the case
of the application of an anatomic protocol, and was carried
out in a few seconds.
The protocol was developed using Smart Analyzer soft-
ware and, starting from the acquisition of the gesture with
the optoelectronic system, allowed everyone to compute the
data automatically, using the related protocol.
The protocol permits an easy employment in clinic
analysis, thanks to the simple movements requested, the
poor number of trails, the little duration, the complete
noninvasive and natural conditions of testing. These charac-
teristics suggest the applicability of this protocol with regard
not only to Parkinson’s Disease but also to other ﬁelds of
motor and cognitive evaluation. Other parameters, such as
drawing velocity or drawing sequence, could be evaluated.
Besides, the protocol could be employed for the quantitative
characterization of other graphic movements (including
writing), particularly suitable for clinical applications.
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